Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andreas Varkaris, Ph.D., M.D.

Concepts (155)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Proto-Oncogene Proteins c-met320155831.170 Why?
src-Family Kinases320145830.970 Why?
Phenylthiohydantoin120191680.750 Why?
Radium12016580.680 Why?
Prostatic Neoplasms11201599720.660 Why?
Interleukin-8120196690.630 Why?
Receptor, IGF Type 1220133760.550 Why?
Hepatocyte Growth Factor220132840.540 Why?
Anilides220153980.510 Why?
Vascular Endothelial Growth Factor Receptor-2120155920.490 Why?
Interleukin-62201930080.450 Why?
Insulin-Like Growth Factor I3201319710.420 Why?
Vascular Endothelial Growth Factor A2201934460.420 Why?
Neoplasms, Second Primary120169480.410 Why?
Liver Transplantation1201719030.350 Why?
Carcinoma, Hepatocellular1201718580.330 Why?
Xenograft Model Antitumor Assays7201736880.330 Why?
Protein Kinase Inhibitors4202050380.310 Why?
MicroRNAs2201934900.310 Why?
Carcinoma, Renal Cell1201926990.310 Why?
Carcinoma, Non-Small-Cell Lung2202042630.300 Why?
Prostate1201113110.290 Why?
Pyridines2201526970.280 Why?
Kidney Neoplasms1201937470.270 Why?
Colorectal Neoplasms2201957530.260 Why?
Bone Neoplasms4201624930.260 Why?
Neoplasm Recurrence, Local2201979840.260 Why?
Liver Neoplasms1201737960.250 Why?
Leukemia, Myeloid, Acute1201628270.250 Why?
Antineoplastic Agents72020135720.240 Why?
Antineoplastic Combined Chemotherapy Protocols22019104650.220 Why?
Signal Transduction72015237960.200 Why?
Inflammation1201989740.200 Why?
Molecular Targeted Therapy1201127150.200 Why?
Fatal Outcome3202019350.200 Why?
Lung Neoplasms22020113480.200 Why?
Orchiectomy220114680.190 Why?
Hypernatremia12018720.190 Why?
Brain Neoplasms1201982970.180 Why?
Neoplasm Metastasis3201952330.170 Why?
Cell Transformation, Neoplastic2202030640.170 Why?
Small Cell Lung Carcinoma120203110.170 Why?
Proto-Oncogene Proteins c-yes12015190.160 Why?
Hyponatremia120182940.160 Why?
Clinical Trials, Phase II as Topic220155880.150 Why?
Phosphorylation4201588790.150 Why?
Focal Adhesion Kinase 1120151310.150 Why?
Cell Line, Tumor72020165810.150 Why?
Male2020203390260.150 Why?
Chitosan120151280.150 Why?
Receptor, Fibroblast Growth Factor, Type 1120152460.140 Why?
Sodium1201815160.140 Why?
Ossification, Heterotopic120152210.130 Why?
Proto-Oncogene Proteins c-bcl-21202013780.130 Why?
Tumor Burden2201518830.120 Why?
Gene Expression Regulation, Neoplastic3201984190.120 Why?
Neoplasms, Hormone-Dependent220134320.120 Why?
Ubiquitin-Protein Ligases1202016410.110 Why?
Apoptosis42020102640.110 Why?
Multicenter Studies as Topic1201514140.110 Why?
Humans2320206483300.110 Why?
Drug Resistance, Neoplasm2201549220.110 Why?
Taxoids220137070.110 Why?
Gene Knockdown Techniques1201517090.110 Why?
Gene Transfer Techniques1201512980.100 Why?
Lymphatic Metastasis1201730210.100 Why?
Bone Diseases120123880.100 Why?
Receptor, Insulin120128440.100 Why?
Aged820201545330.100 Why?
Prognosis22019275840.090 Why?
Receptors, Androgen120149540.090 Why?
Neoplasm Transplantation1201323150.090 Why?
Integrins120138750.090 Why?
Drug Design2201111570.090 Why?
Heart Diseases1202025660.090 Why?
Autophagy1201511910.090 Why?
Disease-Free Survival1201970490.090 Why?
RNA Interference2201531440.080 Why?
Recurrence1201979750.080 Why?
Disease Models, Animal22017180140.080 Why?
Mice, Nude4201540460.080 Why?
Ligands1201331010.080 Why?
Enzyme Activation1201339790.080 Why?
Cardiac Surgical Procedures1202032230.080 Why?
Carcinoma, Squamous Cell1202038940.070 Why?
Bone and Bones1201524580.070 Why?
Survival Rate12019131410.070 Why?
Mice72017787360.070 Why?
Animals1020171677580.070 Why?
Neoplasm Staging22017109700.070 Why?
Nanoparticles1201519680.070 Why?
Cell Movement2201556740.070 Why?
Neovascularization, Pathologic1201428130.060 Why?
Randomized Controlled Trials as Topic1201988710.060 Why?
RNA, Small Interfering1201337410.060 Why?
Pandemics1202047270.060 Why?
Membrane Proteins1202080420.060 Why?
Protein Binding1201499050.060 Why?
Cell Proliferation52015108120.050 Why?
Follow-Up Studies22019384640.050 Why?
Positron-Emission Tomography1201556170.050 Why?
Transcription, Genetic1201381200.050 Why?
Algorithms12018129950.050 Why?
Clinical Trials as Topic2201178820.050 Why?
Female720203597670.040 Why?
Transfection2201564200.040 Why?
Ubiquitination120209510.040 Why?
Thiazoles2201314840.040 Why?
Enzyme-Linked Immunosorbent Assay2201340910.040 Why?
Disease Progression12011126600.040 Why?
Middle Aged520202078600.030 Why?
X-Ray Microtomography120153980.030 Why?
Neoplasms12020182440.030 Why?
Multiple Myeloma1200945090.030 Why?
Stress, Physiological1202014740.030 Why?
Prostate-Specific Antigen2201121550.030 Why?
Clinical Trials, Phase I as Topic120132950.030 Why?
Treatment Outcome22015580890.030 Why?
3T3 Cells1201311660.030 Why?
Triazines120123090.030 Why?
Pyrimidines2201327290.030 Why?
Up-Regulation1202043800.030 Why?
Immunoprecipitation120129860.030 Why?
Aged, 80 and over32020570230.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201551920.020 Why?
Critical Illness1201821590.020 Why?
Osteoblasts1201312010.020 Why?
Mitochondria1202034300.020 Why?
Prednisone1201115560.020 Why?
Intensive Care Units1201829900.020 Why?
Comorbidity12020102910.020 Why?
Infusions, Intravenous1201123420.020 Why?
Tumor Cells, Cultured1201267780.020 Why?
Blotting, Western1201257860.020 Why?
Cell Cycle1201231040.020 Why?
Proto-Oncogene Proteins c-akt1201225120.020 Why?
Administration, Oral1201138840.020 Why?
Pyrazoles1201217080.020 Why?
Predictive Value of Tests12018148400.020 Why?
Prostatectomy1201117310.020 Why?
Drug Therapy, Combination1201265070.010 Why?
Drug Administration Schedule1201151740.010 Why?
Immunohistochemistry12015120550.010 Why?
Time Factors22015414510.010 Why?
Weight Loss1201122380.010 Why?
NF-kappa B1200925320.010 Why?
Combined Modality Therapy1201189840.010 Why?
Cell Survival1200963430.010 Why?
Enzyme Inhibitors1200940050.010 Why?
Pain1201141110.010 Why?
Young Adult12018527630.010 Why?
Antibodies, Monoclonal1200997410.010 Why?
Quality of Life1201198230.010 Why?
Adult120182033850.000 Why?
Retrospective Studies12011613510.000 Why?
Varkaris's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (155)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.